Article info
Original articles
Expression of GRK2 and IGF1R in hepatocellular carcinoma: clinicopathological and prognostic significance
- Correspondence to Dr Ye Jin, Clinical Research Laboratory, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing 100730, China; jinye0320{at}me.com
Citation
Expression of GRK2 and IGF1R in hepatocellular carcinoma: clinicopathological and prognostic significance
Publication history
- Received July 6, 2016
- Revised January 18, 2017
- Accepted January 25, 2017
- First published February 15, 2017.
Online issue publication
May 02, 2019
Article Versions
- Previous version (22 August 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/